The i-SIGHT Clinical Study of the i-Lumen AMD in patients with nonexudative (dry) AMD in the United States has been completed.  Additional information may be found here NCT05447650.

​

The i-SIGHT2 Clinical Study of the i-Lumen AMD in patients with intermediate to advanced nonexudative (dry) AMD is currently enrolling in Australia and New Zealand, and will be soon be enrolling in the United Kingdom.  Additional information may be found here NCT06662162 or at i-sight2study.com.